Skip to main content

Biomedical, Clinical & Life Sciences

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Three RFAS - PAR-23-286, PAR-23-287, and/or PAR-23-288) - October 2026 Deadline

Apply to Internal Competition // Limit: 4* (see below) // Tickets Available: 4

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 1 

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Limiting Language
Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288).

Scientific Areas

  • (A) Cancer Data Science: For the purposes of this K99/R00 award, cancer data science is defined as an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies.
  • (B) Cancer Control Science: For the purposes of this K99/R00 award, cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy.
  • (C) Molecular/Precision Cancer Prevention: For the purpose of this K99/R00 award, early translational research in cancer prevention is defined as basic research to understand mechanisms of cancer formation, development and progression of cancer precursors, and to translate basic biological knowledge into novel human interventions and human-centered adaption of current interventions with the potential to reduce cancer risk, incidence, and mortality, and improve quality of life. This includes but is not limited to research in molecular and systems biology, diagnostics, vaccine and drug development, pharmacology, and biomedical engineering.
  • (D) Other Cancer Research: For the purposes of this K99/R00 award, "Other Cancer Research" includes all scientific fields supported by the NCI that are not included in (A), (B) or (C). Applicants proposing research in (D) "Other Cancer Research" may apply only if it is reasonable to expect their candidates to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees."
Funding Type
External Deadline
10/14/2026
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Rita Allen Foundation Scholars Program

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

Limiting Language
One nominated candidate per eligible institution is accepted per year

Program Overview
The Rita Allen Foundation Scholars program funds basic biomedical research in the fields of cancer, immunology, and neuroscience, as well as pain, through the Rita Allen Foundation Award in Pain. The Rita Allen Foundation Scholars program has supported more than 200 scientists since 1976. The program embraces innovative research with above-average risk and groundbreaking possibilities. Scholars have gone on to win the Nobel Prize in Physiology or Medicine, the National Medal of Science, the Wolf Prize in Medicine and the Breakthrough Prize in Life Sciences.

Full sponsor guidelines are linked here. 

Award Amount
Scholars can receive up to $110,000 per year for a maximum of five years. Recipients of the Award in Pain can be granted $50,000 per year for up to three years.

Eligibility
To be eligible for a Rita Allen Foundation Scholars Award, candidates must either apply through the Scholars Award in Pain or be nominated by an eligible institution and have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in research in one of the relevant fields (cancer, immunology, neuroscience. or pain). United States citizenship is not a requirement; however, awardees must be legally employed at the time of application at a U.S. degree-granting or research institution that is an invited participant in the Rita Allen Foundation Scholars Program. Awards are made to the 501(c)(3) organization; awards are not made to an individual. Scholars must perform research at a non-profit institution in the U.S. during the entire period of Rita Allen Foundation support.

Institutions should consider the following when considering whom to nominate for the Rita Allen Foundation Scholars program: 

  • Candidates should be independent investigators in the early stages of their careers and research. 
  • The caliber of early-stage investigators suggests nominees would be appointed to tenure-track positions at their respective institutions. 
  • It is preferable that candidates be in the first three years of their tenure track. (This is taken into consideration in the rating of applications by the Scientific Advisory Committee.) 
  • A senior postdoc should not be a candidate; wait until s/he is in a tenure-track position, as described. 
  • Associate professors should not be candidates. 
  • Candidates must have received committed startup funds from their respective institutions. 
  • Candidates must have lab space from their institutions. 

Rita Allen Foundation Scholars may not accept an award from the Beckman Young Investigator Program, Pew Scholars Program in the Biomedical Sciences, Searle Scholars Program, or Vallee Scholars Program that would take effect beginning in year one of the RAF award. Rita Allen Scholars may apply for awards from these organizations that would take effect beginning in year two of the RAF award. Other sources of funding also may influence selection. 

Funding Type
External Deadline
9/3/2026 (LOI; Anticipated)
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Medical Student Education Program (MSE)

Request Ticket // Limit: 1 (COM-T) // Tickets Available: 1 

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.


Purpose
The purpose of the Medical Student Education (MSE) Program is to provide support to public medical schools in states ranked in the top quartile for projected primary care provider shortages. to expand or enhance education for medical students preparing to become physicians. This expansion can include funding for direct student supports which help students be successful in medical school, as well as for infrastructure development, maintenance, equipment, and minor renovations or alterations. The program is designed to prepare and encourage medical students to choose residencies and careers in primary care and serve Tribal, rural and other areas with primary care provider shortages in those states after they complete their residency.

  • Increase the number of primary care physicians practicing in states with a projected primary care physician shortage, particularly in rural Tribal and other areas with primary care provider shortages.
Funding Type
External Deadline
9/1/2026

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs. Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts

The RCC will lead, manage, and harmonize efforts for the Consortium including 1) providing management and administrative support; 2) providing leadership and expertise on statistical design and analysis, 3) providing research coordination with a central laboratory, 4) harmonizing data collection methods and use of common data elements, 5) developing the database; 6) conducting data management and data analyses for Consortium studies; and 7) fostering research collaborations. This NOFO uses a cooperative agreement mechanism (U24) and runs in parallel with a companion NOFO (RFA-DK-27-121).

Full sponsor guidelines are linked here. 
 

Funding Type
External Deadline
10/9/2026
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.


Purpose
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs.  Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts. 

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
10/9/2026
Internal Deadline
Internal Time
5:00PM
Solicitation Type

FY 2026 Susan Harwood Training Grant Program (Targeted Topic Training and Training and Educational Materials Development Grants)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
If an organization submits multiple applications for this or other Harwood funding opportunities, OSHA will review the last viable application package submitted.

Grant Types

  • Targeted Topic Training 
    Supports educational programs that identify and prevent workplace hazards and requires applicants to conduct training on OSHA-designated workplace safety and health hazards
  • Training and Educational Materials Development
    Supports the.development of quality, classroom-ready training and educational materials that identify and prevent workplace hazards.

     

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed.

Purpose
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
9/24/2026
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Small Health Care Provider Quality Improvement Program

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.

Summary
The Small Health Care Provider Quality Improvement Program supports the planning and implementation of quality improvement activities for rural primary care providers or providers of health care services, such as critical access hospitals (CAH), rural health clinics (RHC), or a network of rural health providers, to increase access to high quality health care services and improve health.

Funding Type
External Deadline
8/6/2026

Scaling Evidence-Based Falls Prevention Programs

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
If you submit the same application more than once under this notice of funding opportunity (NOFO), we will only acknowledge the last on-time submission.

Only one grant will be awarded in any one state.

Summary
Reducing falls among older adults is a national priority and is in alignment with this administration’s efforts to Make America Healthy Again. The U.S. Department of Health and Human Services (HHS), through the Administration for Community Living (ACL), is coordinating a cross-agency response to significantly reduce the incidence of falls among older adults. While HHS has invested in falls prevention for decades, the work was often siloed within agencies, for specific providers, and/or in specific communities. This effort, informed by the National Falls Prevention Action Plan [PDF], seeks to bring together tools and program investments across ACL, the Centers for Disease Control and Prevention (CDC), the Health Resources and Services Administration (HRSA), the Center for Clinical Standards and Quality in the Centers for Medicare and Medicaid Services, and the National Institute on Aging (NIA) to realize significant progress over the next three years. 

As a part of this initiative, this funding opportunity shall expand and scale the evidence- based Stepping On program and STEADI clinical intervention for adults 60 and older, prioritizing those with the greatest social and economic need. HRSA will be working with Federally Qualified Health Centers to screen for falls risk using STEADI as another part of this coordinated effort. This funding opportunity advances HHS’ Make America Healthy Again (MAHA) agenda by empowering older adults to manage their own health, reducing clinical dependence, and building community infrastructure that sustains healthy behaviors. It is expected that adults between ages 60–70 will make up at least 50% of the participants, through a required partnership model using statewide reach and strong partnerships with state level organizations. Outreach and engagement efforts will prioritize populations that face barriers related to falls, ensuring meaningful reach and participation, while maintaining inclusive program access for all eligible adults in alignment with the Older Americans Act.

Scholarships for Disadvantaged Students (SDS)

Request Ticket (include health profession degree program) // One per health profession degree program (see eligibility below)

Limiting Language
You may submit more than one application under the same Unique Entity Identifier (UEI) if each proposes a distinct project. We will only review your last validated application for each distinct project before the deadline. 

You may not submit more than one application per health professions degree program. If you submit more than one application, we will only accept the last on-time submission. 

While multiple applications from an institution are allowed, only a maximum of three per institution may be funded. Collaborative proposals are not allowed.

Eligible Health Profession Degree Programs
Eligible health professions schools include the following: 

  1. Medicine (Doctor of allopathic medicine, Doctor of osteopathic medicine); 
  2. Dentistry (Doctor of dentistry); 
  3. Other health disciplines (Doctor of veterinary medicine, Doctor of optometry, Doctor of podiatry medicine, Doctor of pharmacy, Doctor of chiropractic medicine); 
  4. Behavioral and mental health (Graduate degree in clinical psychology; Graduate degree in clinical social work; Graduate degree in gerontological counseling; Graduate degree in marriage and family therapy; Graduate degree in mental health counseling; Graduate degree in rehabilitation counseling); 
  5. Public health (Graduate degree in health administration; Graduate degree in public health); 
  6. Allied health (Bachelor's and graduate degrees in dietetics; Graduate degree in audiology; Graduate degree in occupational therapy; Graduate degree in physical therapy; Graduate degree in speech pathology; Bachelor's and graduate degrees in dental hygiene; Bachelor's and graduate degrees in medical laboratory technology, Bachelor's degree in radiologic technology); 
  7. Nursing (Associate, bachelor's, and graduate degrees in nursing (pre-nursing is not eligible)); 
  8. Midwifery (Certified nursing and non-nursing graduate degrees in midwifery (pre-nursing or pre-midwifery is not eligible));
  9. Physician Assistant (Graduate degree in physician assistant studies).

Summary
The Scholarships for Disadvantaged Students (SDS) program increases the health professionsand nursing workforce by providing awards to eligible health professions schools for use in awarding scholarships to students from disadvantaged backgrounds who have a financial need.

Funding Type
External Deadline
7/28/2026